Differentiation of lactotrope precursor GHFT cells in response to Fibroblast Growth Factor-2

dc.contributor.authorLópez-Fernandez, Judith
dc.contributor.authorPalacios, Daniela
dc.contributor.authorCastillo, Ana I.
dc.contributor.authorTolon, Rosa M.
dc.contributor.authorAranda, Ana
dc.contributor.authorKarin, Michael
dc.date.accessioned2021-05-04T16:01:03Z
dc.date.available2021-05-04T16:01:03Z
dc.date.issued2000-07-14
dc.date.updated2021-05-04T16:01:03Z
dc.description.abstractThe mechanisms that control the emergence of different anterior pituitary cells from a common stem cell population are largely unknown. The immortalized GHFT cells derived from targeted expression of SV40 T antigen to mouse pituitary display characteristics of somatolactotropic progenitors in that they express the transcription factor GHF-1 (Pit-1) but not growth hormone (GH) or prolactin (PRL). We searched for factors capable of inducing lactotropic differentiation of GHFT cells. PRL gene expression was not observed in cells subjected to a variety of stimuli, which induce PRL gene expression in mature lactotropes. Only fibroblast growth factor-2 (FGF-2) was able to initiate the transcription, synthesis, and release of PRL in GHFT cells. However, induction of PRL expression was incomplete in FGF-2-treated cells, suggesting that additional factors are necessary to attain high levels of PRL transcription in fully differentiated lactotropes. We also show that the FGF-2 response element is located in the proximal PRL promoter. Stimulation of PRL expression by FGF-2 requires endogenous Ets factors and these factors as well as GHF-1 are expressed at low levels in the committed precursor, suggesting that these low levels are limiting for full PRL expression. Moreover, FGF-2 effect on lactotrope differentiation is mediated, at least partially, by stimulation of the Ras-signaling pathway. Our results suggest that, indeed, GHFT cells represent a valid model for studying lactotropic differentiation and that FGF-2 could play a key role both in initiating lactotrope differentiation and maintaining PRL expression.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec183278
dc.identifier.issn0021-9258
dc.identifier.pmid10801832
dc.identifier.urihttps://hdl.handle.net/2445/177013
dc.language.isoeng
dc.publisherAmerican Society for Biochemistry and Molecular Biology
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1074/jbc.M002129200
dc.relation.ispartofJournal of Biological Chemistry, 2000, vol. 275, num. 28, p. 21653-21660
dc.relation.urihttps://doi.org/10.1074/jbc.M002129200
dc.rights(c) American Society for Biochemistry and Molecular Biology, 2000
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationDiferenciació cel·lular
dc.subject.classificationProlactina
dc.subject.classificationEfectes secundaris dels medicaments
dc.subject.otherCell diferentiation
dc.subject.otherProlactin
dc.subject.otherDrug side effects
dc.titleDifferentiation of lactotrope precursor GHFT cells in response to Fibroblast Growth Factor-2
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
183278.pdf
Mida:
623.05 KB
Format:
Adobe Portable Document Format